Bifogade filer
PDF
Kurs
0,00%
Likviditet
0,79 MDKK
Kalender
| Est. tid* | ||
| 2026-02-03 | 08:00 | Bokslutskommuniké 2025 |
| 2025-10-21 | 07:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-22 | 07:00 | Kvartalsrapport 2025-Q2 |
| 2025-04-29 | - | Kvartalsrapport 2025-Q1 |
| 2025-03-13 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
| 2025-03-12 | - | Årsstämma |
| 2025-02-05 | - | Bokslutskommuniké 2024 |
| 2024-10-22 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-23 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-23 | - | Kvartalsrapport 2024-Q1 |
| 2024-03-13 | - | Årsstämma |
| 2024-03-13 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
| 2024-03-12 | - | Årsstämma |
| 2024-01-30 | - | Bokslutskommuniké 2023 |
| 2023-10-24 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-25 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-25 | - | Kvartalsrapport 2023-Q1 |
| 2023-03-13 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
| 2023-03-10 | - | Årsstämma |
| 2023-01-31 | - | Bokslutskommuniké 2022 |
| 2022-10-25 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-21 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-26 | - | Kvartalsrapport 2022-Q1 |
| 2022-03-09 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
| 2022-03-08 | - | Årsstämma |
| 2022-02-01 | - | Bokslutskommuniké 2021 |
| 2021-10-26 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-22 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-27 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-09 | - | X-dag ordinarie utdelning EMBLA 0.00 DKK |
| 2021-03-08 | - | Årsstämma |
| 2021-02-02 | - | Bokslutskommuniké 2020 |
| 2020-10-27 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-23 | - | Kvartalsrapport 2020-Q2 |
| 2020-04-30 | - | Kvartalsrapport 2020-Q1 |
| 2020-03-13 | - | X-dag ordinarie utdelning EMBLA 0.15 DKK |
| 2020-03-12 | - | Årsstämma |
| 2020-02-04 | - | Bokslutskommuniké 2019 |
| 2019-10-22 | - | Kvartalsrapport 2019-Q3 |
| 2019-07-25 | - | Kvartalsrapport 2019-Q2 |
| 2019-04-30 | - | Kvartalsrapport 2019-Q1 |
| 2019-03-08 | - | X-dag ordinarie utdelning EMBLA 0.14 DKK |
| 2019-03-07 | - | Årsstämma |
| 2019-02-05 | - | Bokslutskommuniké 2018 |
| 2018-10-24 | - | Kvartalsrapport 2018-Q3 |
| 2018-07-25 | - | Kvartalsrapport 2018-Q2 |
| 2018-04-25 | - | Kvartalsrapport 2018-Q1 |
| 2018-03-09 | - | X-dag ordinarie utdelning EMBLA 0.13 DKK |
| 2018-03-08 | - | Årsstämma |
| 2018-02-05 | - | Bokslutskommuniké 2017 |
| 2017-10-24 | - | Kvartalsrapport 2017-Q3 |
| 2017-07-25 | - | Kvartalsrapport 2017-Q2 |
| 2017-04-27 | - | Kvartalsrapport 2017-Q1 |
| 2017-03-10 | - | X-dag ordinarie utdelning EMBLA 0.12 DKK |
| 2016-03-11 | - | X-dag ordinarie utdelning EMBLA 0.12 DKK |
| 2016-03-10 | - | Årsstämma |
| 2016-02-02 | - | Bokslutskommuniké 2015 |
| 2015-10-22 | - | Kvartalsrapport 2015-Q3 |
| 2015-07-23 | - | Kvartalsrapport 2015-Q2 |
| 2015-04-29 | - | Kvartalsrapport 2015-Q1 |
| 2015-03-12 | - | Årsstämma |
| 2015-02-05 | - | Bokslutskommuniké 2014 |
| 2014-10-24 | - | Analytiker möte 2014 |
| 2014-10-23 | - | Kvartalsrapport 2014-Q3 |
| 2014-07-25 | - | Analytiker möte 2014 |
| 2014-07-24 | - | Kvartalsrapport 2014-Q2 |
| 2014-04-30 | - | Analytiker möte 2014 |
| 2014-04-29 | - | Kvartalsrapport 2014-Q1 |
| 2014-03-14 | - | Årsstämma |
| 2014-02-05 | - | Bokslutskommuniké 2013 |
| 2013-10-24 | - | Analytiker möte 2013 |
| 2013-10-23 | - | Kvartalsrapport 2013-Q3 |
| 2013-07-24 | - | Kvartalsrapport 2013-Q2 |
| 2013-04-24 | - | Kvartalsrapport 2013-Q1 |
| 2013-03-15 | - | Årsstämma |
| 2013-02-06 | - | Bokslutskommuniké 2012 |
| 2012-11-28 | - | Kapitalmarknadsdag 2012 |
| 2012-11-27 | - | Kapitalmarknadsdag 2012 |
| 2012-10-24 | - | Analytiker möte 2012 |
| 2012-10-23 | - | Kvartalsrapport 2012-Q3 |
| 2012-07-25 | - | Kvartalsrapport 2012-Q2 |
| 2012-04-24 | - | Kvartalsrapport 2012-Q1 |
| 2012-03-16 | - | Årsstämma |
| 2012-02-08 | - | Bokslutskommuniké 2011 |
| 2011-10-27 | - | Kvartalsrapport 2011-Q3 |
| 2011-07-28 | - | Kvartalsrapport 2011-Q2 |
| 2011-03-04 | - | Årsstämma |
Beskrivning
| Land | Island |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Announcement no. 40/2022
11 July 2022
Össur Appoints Gudny Arna Sveinsdottir as Chief Financial Officer
Gudny Arna Sveinsdottir has been appointed Chief Financial Officer (CFO) of Össur and will join the Össur Executive Committee on 1 September 2022. Mrs. Sveinsdottir held finance roles at Kvika Bank and subsidiaries for the past year, and prior to that, she was at Teva Pharmaceuticals/Actavis for ten years, including as the CFO of Teva Pharmaceutical Generic R&D. During her time at Teva, she worked and lived in Switzerland and in the US. Mrs. Sveinsdottir was an independent consultant to financial institutions in Iceland before joining Teva and worked in various finance roles at Kaupthing Bank 2001-2008, including as the CFO. Prior to that, she worked at Eimskip in Iceland and PWC in Stockholm. Mrs. Sveinsdottir has a Master's degree in Accounting and Finance from the University of Uppsala in Sweden and a Cand.oecon. degree from the University of Iceland.
"We are very pleased to have Gudny Arna Sveinsdottir join Össur as our CFO. Her financial acumen and extensive experience, coupled with her collaborative mindset and impressive leadership skills, will complement our performance-oriented culture. We look forward to welcoming Mrs. Sveinsdottir in her new role," said Sveinn Sölvason, President and CEO of Össur.
Further information
Edda Lára Lúðvígsdóttir, Investor Relations Director, eludvigsdottir@ossur.com,+354 844 4759
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail, please register at http://www.ossur.com/investors
About Össur
Össur (Nasdaq Copenhagen: OSSR) is a global leader in non-invasive orthopaedics that helps people live a Life Without Limitations. A recognized "Technology Pioneer" with a rich 50-year history, Össur focuses on improving people's mobility through the delivery of innovative technologies in Prosthetics and Bracing & Supports. Significant investment in research and development have led to over 2,000 patents, award-winning designs, successful clinical outcomes, and consistently strong market positions. Össur is signatory to the UN Global Compact, UN Women's Empowerment Principles, contributes to the UN Sustainable Development Goals and became Carbon Neutral in 2021. Össur operates globally and employs around 4,000 employees. www.ossur.com